Taken together, our findings indicate that C1QC and CCL18, as intermediaries between DN and obesity, may play major roles in the development of type 2 DN and obesity and may constitute the pathological mechanism by which obesity contributes to DN. This evidence concerns the gene CCL18 and liver dysplastic nodule.